Showing results (341-350 of 395) with videos related to
Sort By:
Pageof 40
Nature Cardiovascular Research|August 28, 2024
Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditisChristian Perez-Shibayama, Cristina Gil-Cruz, Nadine Cadosch, et al.Nature Cardiovascular Research|August 28, 2024
The spectrum and systemic associations of microvascular dysfunction in the heart and other organsMaria Emfietzoglou, Dimitrios Terentes-Printzios, Rafail A Kotronias, et al.Nature Cardiovascular Research|August 28, 2024
Myocardial ultrastructure of human heart failure with preserved ejection fractionMariam Meddeb, Navid Koleini, Aleksandra Binek, et al.Nature Cardiovascular Research|August 28, 2024
Macrophages upregulate mural cell-like markers and support healing of ischemic injury by adopting functions important for vascular supportCatarina Amoedo-Leite, Kristel Parv, Chiara Testini, et al.Nature Cardiovascular Research|August 28, 2024
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failureChristiane E Angermann, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez, et al.Nature Cardiovascular Research|August 28, 2024
The pathological maelstrom of COVID-19 and cardiovascular diseaseMauro Giacca, Ajay M ShahNature Cardiovascular Research|August 28, 2024
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertensionOlivier Boucherat, Tetsuro Yokokawa, Vinod Krishna, et al.Nature Cardiovascular Research|August 28, 2024
A KLF2-BMPER-Smad1/5 checkpoint regulates high fluid shear stress-mediated artery remodelingHanqiang Deng, Jiasheng Zhang, Yewei Wang, et al.Nature Cardiovascular Research|August 28, 2024
The role of early-phase trials and real-world evidence in drug developmentHarriette G C Van Spall, Arnaud Bastien, Bernard Gersh, et al.Nature Cardiovascular Research|August 28, 2024
Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trialHamdi A Jama, Dakota Rhys-Jones, Michael Nakai, et al.Pageof 40